A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Public ClinicalTrials.gov record NCT06713239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Comparison of Personalized Management for Medical and Interventional Therapy Based On Coronary Atherosclerotic Plaque Versus Usual Care for Symptomatic Patients With Suspicion of CAD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
PARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with suspicion of coronary artery disease (CAD), using a CT-based coronary atherosclerotic plaque assessment by AI-enabled quantitative software improves: certainty for diagnosis of CAD, control of CAD risk factors and efficiency of ICA referral with appropriate PCI compared to the usual care strategy based on current AHA/ACC guidelines for care of symptomatic patients with suspicion of CAD.
Study identification
- NCT ID
- NCT06713239
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Jun 4, 2026
2024 – 2026
United States locations
- U.S. sites
- 21
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology Associates of Mobile | Mobile | Alabama | 36608 | — |
| Valiance Clinical Research- Huntington Park | Huntington Park | California | 90255 | — |
| Cardiovascular Institute of San Diego | San Diego | California | 91911 | — |
| Valiance Clinical Research- Tarzana | Tarzana | California | 91356 | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| Intermountain Health Saint Joseph Hospital | Broomfield | Colorado | 80021 | — |
| Tampa Cardiovascular Interventions and Research | Tampa | Florida | 33614 | — |
| Flourish Research | Winter Park | Florida | 32789 | — |
| Endeavor Health Clinical Operations | Evanston | Illinois | 60201 | — |
| MercyOne Des Moines Medical Center | West Des Moines | Iowa | 50266 | — |
| Saint Elizabeth Medical Center | Edgewood | Kentucky | 41017 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| Flourish- Bowie | Bowie | Maryland | 20715 | — |
| St. Louis Heart and Vascular | Bridgeton | Missouri | 63044 | — |
| Advanced Heart and Vascular Institute of Hunterdon | Flemington | New Jersey | 08822 | — |
| Capital Cardiology Associates | Albany | New York | 12211 | — |
| University of Cincinnatti | Cincinnati | Ohio | 45221 | — |
| Oklahoma Cardiovascular Research Group | Oklahoma City | Oklahoma | 73120 | — |
| The University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| Medical City Fort Worth Hospital | Fort Worth | Texas | 76104 | — |
| Chippenham and Johnston Willis Hospitals | Richmond | Virginia | 23225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06713239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06713239 live on ClinicalTrials.gov.